Loading...
Future Epilepsy Trial Costs And Financing Needs Will Pressure Long-Term Earnings Potential
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
251.9%7D
0.2%1Y
251.9%7D
0.2%You can edit this narrative until Dec 17 12:10 AM. Then, changes will post as Updates.